These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16932540)

  • 1. The genetics of Parkinson disease: Implications for neurological care.
    Klein C; Schlossmacher MG
    Nat Clin Pract Neurol; 2006 Mar; 2(3):136-46. PubMed ID: 16932540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of genetics on the diagnosis and care of patients with Parkinson disease.
    Klein C
    Arch Neurol; 2006 Mar; 63(3):328-34. PubMed ID: 16533959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the impact of genes on Parkinson's disease.
    van der Vegt JP; van Nuenen BF; Bloem BR; Klein C; Siebner HR
    Neuroscience; 2009 Nov; 164(1):191-204. PubMed ID: 19409223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder.
    Klein C; Schlossmacher MG
    Neurology; 2007 Nov; 69(22):2093-104. PubMed ID: 17761553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.
    Henchcliffe C; Beal MF
    Nat Clin Pract Neurol; 2008 Nov; 4(11):600-9. PubMed ID: 18978800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The gene products for familial Parkinson's disease provide us hints to elucidate the mechanisms of nigral degeneration].
    Hattori N
    Rinsho Shinkeigaku; 2004 Nov; 44(11):821-3. PubMed ID: 15651302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila.
    Park J; Kim Y; Chung J
    Dis Model Mech; 2009; 2(7-8):336-40. PubMed ID: 19553694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the genetics of Parkinson's disease.
    Rosner S; Giladi N; Orr-Urtreger A
    Acta Pharmacol Sin; 2008 Jan; 29(1):21-34. PubMed ID: 18158863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes.
    Crosiers D; Theuns J; Cras P; Van Broeckhoven C
    J Chem Neuroanat; 2011 Oct; 42(2):131-41. PubMed ID: 21810464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of genes involved in neurodegenerative disorders.
    Pardo LM; van Duijn CM
    Mutat Res; 2005 Dec; 592(1-2):89-101. PubMed ID: 16009383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of genetic studies of Parkinson's disease in Africa.
    Okubadejo NU
    Parkinsonism Relat Disord; 2008; 14(3):177-82. PubMed ID: 17881276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease.
    Luoma PT; Eerola J; Ahola S; Hakonen AH; Hellström O; Kivistö KT; Tienari PJ; Suomalainen A
    Neurology; 2007 Sep; 69(11):1152-9. PubMed ID: 17846414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of Parkinson's disease genetics.
    Lorincz MT
    Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
    Singh MP; Patel S; Dikshit M; Gupta YK
    Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for Parkinson's disease.
    Mochizuki H
    Expert Rev Neurother; 2007 Aug; 7(8):957-60. PubMed ID: 17678490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of Parkinson disease: paradigm shifts and future prospects.
    Farrer MJ
    Nat Rev Genet; 2006 Apr; 7(4):306-18. PubMed ID: 16543934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical biomarkers of Parkinson disease.
    Wu Y; Le W; Jankovic J
    Arch Neurol; 2011 Jan; 68(1):22-30. PubMed ID: 21220674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.